Jim Bohnsack
LinkedIn Copy
Jim — congrats on launching Kolos Partners. been working on outbound origination with lower middle market healthcare investors and your fund has been on my radar. would be good to connect.
Jim — though we share a PE background (you at Kolos, me at Treis in London), I've seen first-hand how challenging early proprietary origination can be. Been helping funds like Mentmore and Wingman with their outbound origination — curious what email infrastructure you're using these days — still mostly on shared IPs like Instantly, or have you moved to private/dedicated senders? Happy to share what's working best for similar lower middle market healthcare funds if useful. — Russ
Email Copy
No email copy generated yet.
Prospect Research
## PROSPECT INFORMATION: Name: Jim Bohnsack Title: Operating Advisor Fund: Kolos Partners Background: CURVE SUMMARY: JIM BOHNSACK CURRENT ROLE & FOCUS Jim is the Chief Strategy & Client Officer at Aspirion, based in Dallas, Texas. He is a senior healthcare executive focused on leveraging artificial intelligence, machine learning, and data analytics to transform Revenue Cycle Management (RCM). His current work centers on combating the rise in clinical denials, managing complex claims (Veterans Affairs, Workers' Comp, MVA), and navigating the regulatory challenges of the No Surprises Act (NSA). Additionally, he serves as an Operating Advisor for Kolos Partners and a Board Member for Janus Health and Nym. PROFESSIONAL BACKGROUND He has over 25 years of experience in the healthcare technology and services sector. Prior to Aspirion, he was the Chief Revenue & Strategy Officer at TransUnion Healthcare, where he led a $200M business unit through a corporate carve-out. His leadership history includes serving as President & CEO of Strivant Health and Senior Vice President at CIOX Health. He began his career in major consulting firms, including Deloitte Consulting and Cap Gemini Ernst & Young. He holds both a BS in Business Administration and an MS in Healthcare Administration from Trinity University, where he has also served as an Adjunct Professor. KEY SKILLS Strategic Planning and Corporate Development; Revenue Cycle Management (RCM); Healthcare Analytics and AI Implementation; Mergers & Acquisitions (M&A); Product Development and Market Entry; Denials Management; P&L Ownership; Thought Leadership. NOTABLE POSTS & QUOTES - March 6, 2026: Jim reposted a hiring call for finance and revenue integrity leaders with hospital experience, highlighting his ongoing focus on talent acquisition in the RCM space. - February 19, 2026: Following a CFO panel at the HFMA Minnesota Chapter Winter Conference, Jim quoted a mantra for the industry: "Don’t admire the problem. Own the problem and the solution." - January 29, 2026: Commenting on ARCM’s development, he noted: "ARCM is building something special. Great team, great sponsors and a market in need…that is a great recipe for success." - January 26, 2026: Engaging with an article on agentic AI, he stated: "The opportunity is right in front of us to take waste out of the system." - December 10, 2025: Addressing the crisis of clinical denials, Jim shared a strong professional warning: "The current denial trend is not sustainable for the provider community... This is NOT a problem that can be solved with more people resources." - November 26, 2025: Jim highlighted personal interests by sharing his excitement to read "The Positive Intent Mindset" by Amer Kaissi, tagged as part of the #TrinityHCADmafia. - October 24, 2025: On the effectiveness of AI in healthcare, he remarked: "Not just hype….the results speak for themselves." - September 5, 2025: Jim participated in a Becker’s Healthcare podcast discussing AI’s transformation of denials management, focusing on efficiency gains and improved appeal outcomes. - February 27, 2025: He emphasized Aspirion's technological edge, stating: "Working with Spencer Allee-Yeh on our technology is one of the reasons Aspirion is different…" Fund details: - Description: Kolos Partners is an investor in and operator of healthcare businesses in the lower middle market. Within healthcare, we focus on subsectors experiencing long-term structural tailwinds and seek to partner with service businesses that support providers, payors, and biopharma companies. Our team brings years of experience in healthcare, private equity, machine learning, and software development. We leverage specialized healthcare operating experience and emerging AI tools to automate business processes and unlock transformative growth for our partner companies. Across everything we do, we strive to have a positive impact on the U.S. healthcare system, patients, and providers – and we seek to partner with companies and executives who share that orientation. - Website: https://kolospartners.com - Location: New York, New York, United States - Lead qualification: Research: - Query: =Kolos Partners Jim Bohnsack recent investments fund thesis - Answer: Jim Bohnsack focuses on healthcare investments, emphasizing AI adoption and transformative growth. Kolos Partners targets subsectors with long-term growth potential. Bohnsack's recent investments align with healthcare innovation and operational efficiency.